
XTANT MEDICAL HOLDINGS INC
XTNTNYSE AMERICANπ #3158 by market capUS Equity
$0.33βΌ $0.09 (β26.39%)
Live1hβ
24hβΌ 26.4%
7dβΌ 26.4%
14dβΌ 23.2%
30dβΌ 22.6%
1yβΌ 47.3%
π¦Market Cap
$46M
Small Cap
πRevenue Growth (YoY)
-0.3%
Declining
πGross Margin
62.3%
High
π΅FCF Margin
8.3%
Moderate
βοΈP/S Ratio
0.5x
Cheap
Otter Score
48
Weak
Trading Snapshot
- Day Range
- $0.32 β $0.33
- 52-Week Range
- $0.39 β $0.95
- Volume
- $3.36B
- Avg Volume
- $2.64B
- Shares Outstanding
- 140.3M
- Next Earnings
- Oct 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $119M
- Last Q Revenue
- $33M
- P/E Ratio
- 34.1
- P/S Ratio
- 0.5x
- EPS (TTM)
- $0.01
- Dividend Yield
- β
Why Investors Own XTNT
- βHigh-growth profile β revenue up +38.5% YoY with expanding US Equity exposure.
- βHealthy economics β 26% gross margin and 4% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
β οΈ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$119Mβ² +34.9% YoY
Gross Margin (TTM)
26.0%β² +3.6% YoY
Operating Income (TTM)
$15Mβ² +34.9% YoY
Free Cash Flow (TTM)
$5Mβ² +34.9% YoY
About XTANT MEDICAL HOLDINGS INC
A company profile for XTANT MEDICAL HOLDINGS INC isnβt available yet β check back soon.
π¦¦
Otter Score Breakdown
βπQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
Overall Score
Weak
48/100
Analyst Price Target
βAverage Target
$0.41
β² +25.6% Upside
High Target$0.49
Low Target$0.37
Based on 13 analysts
Latest News & Updates
π
ReutersΒ·2h ago
XTANT MEDICAL HOLDINGS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
π°οΈ
BloombergΒ·5h ago
Analysts lift XTNT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
π
ReutersΒ·1d ago
XTANT MEDICAL HOLDINGS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.